{
  "id": "TNM_Pancreas_assessment.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2017-06-03",
      "name": "Syeeda S Farruque",
      "organisation": "Cambio Healthcare Systems",
      "email": "models@cambiocds.com"
    },
    "other_contributors": [
      "Dennis Forslund, Cambio Healthcare Systems",
	  "Linda Guttormsdottir"
    ],
    "lifecycle_state": "Author draft",
    "details": {
      "sv": {
        "id": "sv",
        "purpose": "American Joint Committee on Cancers (AJCC) TNM-klassifikation beskriver allvarlighetsgrad av pankreascancer baserat på tumörstorlek, lymfkörtelengagemang och förekomst av metastaser.",
        "keywords": [
          "TNM",
          "TNM-klassifikation",
          "cancer",
          "pankreascancer"
        ],
        "use": "Vardera av komponenterna som utgör TNM graderas enligt följande system.\n\nT - tumörstorlek.\nTX: primärtumör kan ej fastställas\nT0: ingen primärtumör påvisad\nTis: carcinoma in situ\nT1: tumör begränsad till pankreas,  ≤2 cm \nT2: tumör begränsad till pankreas,  >2 cm\nT3: tumör med växt utanför pankreas men utan artärengagemang (truncus coeliacus eller mesenterica superior)\nT4: tumör med engagemang av artärer, magsäck, mjälte, kolon\n\nN - lymfkörtelengagemang:\n\nNX: regionalt lymfkörtelengagemang kan ej fastställas\nN0: inga tumörceller har kunnat påvisas i regionala lymfkörtlar\nN1: tumörceller återfinns i regionala lymfkörtlar\n\nM - fjärrmetastaser:\n\nM0: inga fjärrmetastaser påvisade\nM1: fjärrmetastaser påvisade\n\nSystemet kombinerar TNM ovan och skapar klassifikationer enligt:\n\nStadium 0: TisN0M0\nTumören är begränsad till yttersta lagrena av duktala celler och har inte invaderat djupare vävnad. Den har inte spridit sig utanför pankreas. Dessa tumörer kallas ibland carcinoma in situ eller pankreatisk intraepitelial neoplasi III (PanIn III).\n\nStadium IA: T1N0M0\nTumören är begränsad till pankreas och är ≤2 cm. Ingen förekomst av regionalt lymfkörtelengagemang eller fjärrmetastaser.\n\nStadium IB: T2N0M0\nTumören är begränsad till pankreas och är större än 2cm. Ingen förekomst av regionalt lymfkörtelengagemang eller fjärrmetastaser.\n\nStadium IIA: T3N0M0\nTumören har invaderat omkringliggande vävnad men inte större kärl eller nerver. Ingen förekomst av regionalt lymfkörtelengagemang eller fjärrmetastaser.\n\nStadium IIB: T1-T3N1M0\nTumören är antingen begränsad till pankreas eller växer in i omkringliggande vävnad men inte större kärl eller nerver. Regionalt lymfkörtelengagemang påvisat men ej fjärrmetastaser. \n\nStadium III: T4AnyNM0\nTumören växer utanför pankreas och in i närliggande större kärl och nerver. Regionalt lymfkörtelengagemang kan ses, men inte fjärrmetastaser. \n\nStadium IV: AnyTAnyNM1\nFjärrmetastaser har påvisats.\n\nStadium\t5-årsöverlevnad\nIA\t14%\nIB\t12%\nIIA\t7%\nIIB\t5%\nIII\t3%\nIV\t1%\n",
        "misuse": "TNM-klassifikation kräver data inhämtad med hjälp av högkvalitativa metoder inklusive bilddiagnostik och omfattande lymfkörtelundersökning. ",
        "copyright": "© Cambio Healthcare Systems"
      },
      "en": {
        "id": "en",
        "purpose": "The American Joint Committee on Cancer (AJCC) TNM staging system reports on the severity of pancreatic cancer based on tumor, lymph node and metastasis characteristics. The characteristics of the size of the tumour, the extent of spread to local lymph nodes and body organs. These aspects are captured in 3 ways that make up the mnemonic TNM: T: Tumour size; N: Number of regional lymph nodes affected and M: whether the cancer has spread/metastasised beyond the primary organ and regional nodes. Each major category is further subdivided to help classify the picture further. These subdivisions are given suffixes or numbered as shown below.",
        "keywords": [
          "TNM staging",
          "Pancreatic cancer staging"
        ],
        "use": "The acronyms, T, N and M  are subdivided into subsections and lettered as shown below:\n\nT\nTX: Primary tumor cannot be assessed\nT0: No evidence of primary tumor\nTis: Carcinoma in situ\nT1: Tumor limited to pancreas, ≤2 cm in greatest dimension\nT2: Tumor limited to pancreas, >2 cm in greatest dimension\nT3: Tumor extends beyond pancreas but without involving celiac axis or Superior Mesenteric Artery (SMA)\nT4: Tumor involves celiac axis or SMA (unresectable primary)\n\nN:\n\nNX: Regional lymph nodes cannot be assessed\nN0: No regional lymph node metastasis\nN1: Regional lymph node metastasis\n\nM:\n\nM0: No distant metastasis\nM1: Distant metastasis\n\nThen the staging combines the 3 subdivisions as described above to produce classifications shown:\n\nStage 0: TisN0M0\nThe tumor is confined to the top layers\nof pancreatic duct cells and has not\ninvaded deeper tissues. It has not\nspread outside of the pancreas. These\ntumors are sometimes referred to as\npancreatic carcinoma in situ or\npancreatic intraepithelial neoplasia III\n(PanIn III).\n\nStage IA: T1N0M0\nThe tumor is confined to the pancreas\nand is 2 cm across or smaller (T1). The\ncancer has not spread to nearby lymph\nnodes (N0) or distant sites (M0).\n\nStage IB: T2N0M0\nThe tumor is confined to the pancreas\nand is larger than 2 cm across (T2). The\ncancer has not spread to nearby lymph\nnodes (N0) or distant sites (M0).\n\nStage IIA: T3N0M0\nThe tumor is growing outside the\npancreas but not into major blood\nvessels or nerves (T3). The cancer has\nnot spread to nearby lymph nodes (N0)\nor distant sites (M0).\n\nStage IIB: T1-T3N1M0\nThe tumor is either confined to the\npancreas or growing outside the\npancreas but not into major blood\nvessels or nerves (T1-T3). The cancer\nhas spread to nearby lymph nodes (N1)\nbut not to distant sites (M0).\n\nStage III: T4AnyNM0\nThe tumor is growing outside the\npancreas and into nearby major blood\nvessels or nerves (T4). The cancer may\nor may not have spread to nearby\nlymph nodes (Any N). It has not spread\nto distant sites (M0).\n\nStage IV: AnyTAnyNM1\nThe cancer has spread to distant sites\n(M1).\n\n\n\nStage\t5-year survival rate\nIA\t14%\nIB\t12%\nIIA\t7%\nIIB\t5%\nIII\t3%\nIV\t1%\n\n",
        "misuse": "TNM staging requires supporting evidence from high quality advanced imaging and extensive lymph node evaluation. Other aspects such as tumour grading, whether resectable of not and/or extent of surgical resection should also be taken into account to get a more accurate rounded picture.",
        "copyright": "© Cambio Healthcare Systems"
      }
    },
    "other_details": {
      "references": "Ref. 1: Exocrine and endocrine pancreas. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 241-9.\n\nRef. 2: NIH National Cancer Institute Pancreatic Cancer Treatment (PDQ®)–Health Professional Version. Updated: February 5, 2016. Accessed: 5/18/2016Tempero MA, et al. Pancreatic Adenocarcinoma. J Natl Compr Canc"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0003": {
        "id": "gt0003",
        "model_id": "openEHR-EHR-OBSERVATION.tnm_pancreas_staging.v1",
        "template_id": "openEHR-EHR-OBSERVATION.tnm_pancreas_staging.v1",
        "type": "INPUT",
        "elements": {
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0030]"
          }
        }
      },
      "gt0022": {
        "id": "gt0022",
        "model_id": "openEHR-EHR-EVALUATION.tnm_pancreas_assessment.v1",
        "template_id": "openEHR-EHR-EVALUATION.tnm_pancreas_assessment.v1",
        "type": "OUTPUT",
        "elements": {
          "gt0023": {
            "id": "gt0023",
            "path": "/data[at0001]/items[at0003]"
          }
        }
      }
    },
    "rules": {
      "gt0026": {
        "id": "gt0026",
        "priority": 7,
        "when": [
          "$gt0007|Pancreatic Cancer Stage|==0|local::at0031|Stage 0|"
        ],
        "then": [
          "$gt0023|5 Year Survival|=0|local::at0011|N/A|"
        ]
      },
      "gt0027": {
        "id": "gt0027",
        "priority": 6,
        "when": [
          "$gt0007|Pancreatic Cancer Stage|==1|local::at0032|Stage IA|"
        ],
        "then": [
          "$gt0023|5 Year Survival|=1|local::at0012|14%|"
        ]
      },
      "gt0028": {
        "id": "gt0028",
        "priority": 5,
        "when": [
          "$gt0007|Pancreatic Cancer Stage|==2|local::at0033|Stage IB|"
        ],
        "then": [
          "$gt0023|5 Year Survival|=2|local::at0013|12%|"
        ]
      },
      "gt0029": {
        "id": "gt0029",
        "priority": 4,
        "when": [
          "$gt0007|Pancreatic Cancer Stage|==3|local::at0034|Stage IIA|"
        ],
        "then": [
          "$gt0023|5 Year Survival|=3|local::at0014|7%|"
        ]
      },
      "gt0030": {
        "id": "gt0030",
        "priority": 3,
        "when": [
          "$gt0007|Pancreatic Cancer Stage|==4|local::at0035|Stage IIB|"
        ],
        "then": [
          "$gt0023|5 Year Survival|=4|local::at0015|5%|"
        ]
      },
      "gt0031": {
        "id": "gt0031",
        "priority": 2,
        "when": [
          "$gt0007|Pancreatic Cancer Stage|==5|local::at0036|Stage III|"
        ],
        "then": [
          "$gt0023|5 Year Survival|=5|local::at0016|3%|"
        ]
      },
      "gt0032": {
        "id": "gt0032",
        "priority": 1,
        "when": [
          "$gt0007|Pancreatic Cancer Stage|==6|local::at0037|Stage IV|"
        ],
        "then": [
          "$gt0023|5 Year Survival|=6|local::at0017|1%|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "sv": {
        "id": "sv",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "TNM Pancreas utvärdering",
            "description": "American Joint Committee on Cancers (AJCC) TNM-klassifikation beskriver allvarlighetsgrad av pankreascancer baserat på tumörstorlek, lymfkörtelengagemang och förekomst av metastaser."
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Pankreascancer - klassifikation",
            "description": "*(en) Pancreatic Cancer Stage"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "5-årsöverlevnad",
            "description": "*(en) 5 year survival"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "Pankreascancer - klassifikation",
            "description": "*(en) Pancreatic Cancer Stage"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "Stadium 0 överlevnad"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "Stadium IA överlevnad"
          },
          "gt0028": {
            "id": "gt0028",
            "text": "Stadium IB överlevnad"
          },
          "gt0029": {
            "id": "gt0029",
            "text": "Stadium IIA överlevnad"
          },
          "gt0030": {
            "id": "gt0030",
            "text": "Stadium IIB överlevnad"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "Stadium III överlevnad"
          },
          "gt0032": {
            "id": "gt0032",
            "text": "Stadium IV överlevnad"
          },
          "gt0034": {
            "id": "gt0034",
            "text": "Pankreascancer - klassifikation",
            "description": "*(en) Pancreatic Cancer Stage"
          }
        }
      },
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "TNM Pancreas assessment",
            "description": "The American Joint Committee on Cancer (AJCC) TNM staging system reports on the severity of pancreatic cancer based on tumor, lymph node and metastasis characteristics."
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Pancreatic Cancer Stage",
            "description": "Pancreatic Cancer Stage"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "5 Year Survival",
            "description": "5 year survival"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "Pancreatic Cancer Stage",
            "description": "Pancreatic Cancer Stage"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "Stage 0 Survival"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "Stage IA Survival"
          },
          "gt0028": {
            "id": "gt0028",
            "text": "Stage IB Survival"
          },
          "gt0029": {
            "id": "gt0029",
            "text": "Stage IIA Survival"
          },
          "gt0030": {
            "id": "gt0030",
            "text": "Stage IIB Survival"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "Stage III Survival"
          },
          "gt0032": {
            "id": "gt0032",
            "text": "Stage IV Survival"
          },
          "gt0034": {
            "id": "gt0034",
            "text": "Pancreatic Cancer Stage",
            "description": "Pancreatic Cancer Stage"
          }
        }
      }
    }
  }
}